- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02364739
Evaluate Educational Interventions for Increasing Fertility Knowledge and Awareness (QUESE2)
February 17, 2015 updated by: Fundació Privada Eugin
A Randomized Controlled Trial to Evaluate Two Educational Interventions for Increasing Fertility Knowledge and Awareness in Oocyte Donors
Fertility knowledge and awareness is considered insufficient in women of reproductive age from developed countries.
The objective of this study is to evaluate if educational interventions in oocyte donors increase on their level of fertility knowledge and awareness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Fertility knowledge and awareness is considered insufficient in women of reproductive age from developed countries.
The objective of this study is to evaluate if educational interventions in oocyte donors increase on their level of fertility knowledge and awareness through a RCT.
The investigators will evaluate the effect of the interventions through a questionnaire filled in at first visit (pre-test) and at the end of the treatment (post-test); the investigators will compare the increase in the total score between groups.
Study Type
Interventional
Enrollment (Actual)
201
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08029
- Clinica EUGIN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women candidate to oocyte donation
Exclusion Criteria:
- Previous donations cycles at the center
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Written information
|
Brochure
|
|
Experimental: Written and oral information
|
Written information consists in a brochure with information about fertility, while oral information consists in a tailored oral explanation about the wrong answers to the pre-test (that is related to the brochure).
|
|
No Intervention: No intervention
Control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fertility knowledge increase measured as the difference on total score of the questionnaire at post-test
Time Frame: up to 8 months
|
Difference on total score of the questionnaire about fertility knowledge at post-test, that is filled in between 1 and 8 months after the pre-test (i.e. at the end of the donation cycle).
|
up to 8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Advancement in the reported ideal age for childbearing at post-test
Time Frame: up to 8 months
|
Difference on the reported ideal age for childbearing at post-test, respect to the pre-test
|
up to 8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Désirée García, Fundació Privada Eugin
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
January 1, 2015
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
December 3, 2013
First Submitted That Met QC Criteria
February 17, 2015
First Posted (Estimate)
February 18, 2015
Study Record Updates
Last Update Posted (Estimate)
February 18, 2015
Last Update Submitted That Met QC Criteria
February 17, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- QUESE2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fertility
-
Next Life SciencesClinico Pty LtdRecruitingFertility | Healthy Male Adults | Fertility, MaleAustralia
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationTerminatedFertility Issues | Fertility Disorders | IVF | Sub Fertility, Female | Sub-fertilityGermany
-
Sandstone DiagnosticsCompletedFertility, Male | Sub-Fertility, MaleUnited States
-
Centre Hospitalier Universitaire, AmiensRecruitingOncology | Live Birth Rate | Fertility Preservation | Assisted Reproductive Technology | Reproductive Health | Cancer Remission | Reproductive Outcomes | Fertility Counseling | Psychological Impact | Fertility Observatory | Patient Follow-up | Female Cancer Survivors | Fertility Preservation TechniquesFrance
-
Fundación Santiago Dexeus FontRecruiting
-
Lady Technologies IncActive, not recruiting
-
Ferring PharmaceuticalsTerminatedFertilitySpain, Belgium, Czechia, Denmark, Norway
-
University of NottinghamCompleted
-
Ava AGUniversity Hospital, Zürich; Empa, Swiss Federal Laboratories for Materials... and other collaboratorsCompleted
-
University of SaskatchewanCanadian Institutes of Health Research (CIHR)Completed
Clinical Trials on Written information
-
Copenhagen Trial Unit, Center for Clinical Intervention...Hvidovre University Hospital; Section for Health Services Research, Department...Completed
-
Asociacion Instituto BiodonostiaRecruitingUterine Cervical Neoplasms | Anxiety | Clinical Trial | Early Detection of CancerSpain
-
Carnegie Mellon UniversityICON plcCompletedConsent Forms
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
University Hospitals, LeicesterNational Institute for Health Research, United Kingdom; University of LeicesterCompleted
-
Mid Western Regional Hospital, IrelandCompleted
-
OHSU Knight Cancer InstituteMovember FoundationCompletedCancer Survivor | Prostate CarcinomaUnited States
-
Radboud University Medical CenterUMC Utrecht; St. Antonius Hospital; The Netherlands Cancer Institute; Franciscus... and other collaboratorsCompletedBreast Cancer | Cognitive Decline | Cognitive Symptoms
-
Medical College of WisconsinCompletedPremature BirthUnited States
-
Poitiers University HospitalRecruitingUrinary IncontinenceFrance